Harvard Medical School Intensive Review of Nephrology 2018 (Videos+PDFs)

Harvard Medical School Intensive Review of Nephrology 2018

Harvard Medical School and Brigham and Women’s Hospital Board Review

Product Details

  • Oakstone Price: $1495.
  • Points to Download: 1500 Points
  • Format: 64 Video Files (.mp4 format) + 2 PDF files.
  • File Size: 34.2 GB.
  • Download Link Below.

Download Link:

This post contains protected content. You must be logged in and have 1500 points to unlock it.


Description:

Stay Current with Key Advances

Intensive Review of Nephrology is an extremely thorough CME course, covering all topics included in the ABIM certification and maintenance of certification exams. This well-laid-out program highlights recent advances in the field, along with case-based lectures on topics like membranous nephropathy, renal physiology, renal pathology, glomerulonephritis, metabolic management of kidney stones, etc. It will help you to better:

  • Summarize current/recommended nephrology guidelines
  • Explicate the differential diagnosis of complex clinical presentations of patients with renal disorders
  • Stay up-to-date on an expanding array of therapeutic options for diverse renal disorders
  • Define pathophysiological mechanisms as they apply to management of renal disease
  • Prepare for the ABIM Nephrology certification/recertification exams

Expand Your Skills

Available online or via audio MP3 CDs, Intensive Review of Nephrology provides a maximum of 52.25 AMA PRA Category 1 Credits ™ and 52.25 MOC points and access to unbiased, evidence-based content and case-based reviews so you can expand your knowledge and incorporate the latest guidelines into your daily practice.

Accreditation

The Harvard Medical School is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The Harvard Medical School designates this enduring material for a maximum of 52.25 AMA PRA Category 1 Credits ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Date of Original Release: October 1, 2018
Termination Date: January 31, 2021 (Please note that AMA PRA Category 1 Credits ™ will no longer be issued for the activity after this date)
Estimated Time to Complete the Activity: 52.25 hours

CME credit is awarded upon successful completion of a course evaluation and post-test.

ABIM Medical Knowledge MOC Points

Successful completion of this CME activity enables the participant to earn 52.25 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC points.

On the course evaluation page please indicate “Yes” when asked if you would like to receive ABIM MOC points for your participation in this enduring activity. You will then be required to provide your ABIM ID # and your Date of Birth. Points earned will equal the amount of AMA PRA Category 1 Credits™ claimed.

HMS will upload the participant data, including the points earned, directly to the ABIM so that it will appear on the ABIM diplomates transcript. These points will not appear on your certificate provided at the end of this enduring activity.

Disclosure Policy

Harvard Medical School (HMS) adheres to all ACCME Essential Areas, Standards, and Policies. It is HMS’s policy that those who have influenced the content of a CME activity (e.g. planners, faculty, authors, reviewers and others) disclose all relevant financial relationships with commercial entities so that HMS may identify and resolve any conflicts of interest prior to the activity. These disclosures will be provided in the activity materials along with disclosure of any commercial support received for the activity. Additionally, faculty members have been instructed to disclose any limitations of data and unlabeled or investigational uses of products during their presentations.

Disclosure information for all individuals in control of the content of the activity is located on the disclosure statement in the PDF and printed syllabus.

Learning Objectives

After viewing this program, participants will be better able to:

  • Summarize current/recommended nephrology guidelines in clinical practice
  • Explain the differential diagnosis of complex clinical presentations of patients with renal disorders
  • Identify/integrate current therapeutic options for specific renal disorders
  • Review and interpret up-to-date literature relevant to clinical practice
  • Describe pathophysiological mechanisms as they apply to management of renal disease
  • Apply learning objectives to the ABIM Nephrology certification/recertification examinations

ACGME Competencies

This course is designed to meet one or more of the following Accreditation Council for Graduate Medical Education Competencies:

  • Patient Care and Procedural Skills
  • Medical Knowledge
  • Practice-Based Learning and Improvement

Target Audience

The target audience for the Intensive Review of Nephrology Course is clinical and academic nephrologists, internists, pediatricians, and primary care physicians/trainees preparing for ABIM nephrology certification/recertification examinations and/or seeking a comprehensive update in renal medicine and its subspecialties.

Topics/Speaker:

Glomerulonephritis

  • Renal Physiology for the Boards – Melanie P. Hoenig, MD
  • Basic Concepts of Immunology in Autoimmune Kidney Disease – Ramon Bonegio, MD
  • Renal Pathology in 2018: Part 1 – Helmut G. Rennke, MD
  • Renal Pathology in 2018: Part 2 – Helmut G. Rennke, MD
  • Current Approaches to Urine Sediment Analysis – Martina M. McGrath, MD
  • Challenging Pathology Cases – Helmut G. Rennke, MD
  • IgA Nephropathy – Gerald B. Appel, MD
  • Membranous Nephropathy – David Salant, MD
  • Rapidly Progressive Glomerulonephritis – John L. Niles, MD
  • Update on Lupus Nephritis – Gerald B. Appel, MD
  • Glomerulonephritis: Questions & Answers Session – Gerald B. Appel, MD
  • Metabolic Management of Kidney Stones – Gary Curhan, MD, ScD
  • Anemia Management: Update and Best Practices – Ajay K. Singh, MBBS, FRCP (UK), MBA
  • Must-Know Clinical Images in Nephrology – Ajay K. Singh, MBBS, FRCP (UK), MBA

Electrolytes and Acid Base

  • Workshop: Hyponatremia and Hypernatremia – David B. Mount, MD
  • Electrolyte and Acid Base Disorders Questions & Answers Session – Part 1 – Alan S.L. Yu, MB, BChir
  • Hypokalemia and Hyperkalemia – David B. Mount, MD
  • Acidosis – Alan S.L. Yu, MB, BChir
  • Alkalosis – Alan S.L. Yu, MB, BChir
  • Cases from Renal Grand Rounds at The Brigham – David B. Mount, MD
  • Electrolyte and Acid Base Disorders Questions & Answers Session – Part 2 – Alan S.L. Yu, MB, BChir
  • Genetics and Kidney Disease – Friedhelm Hildebrandt, MD
  • Update on Polycystic Kidney Disease – Peter G. Czarnecki, MD
  • Pediatric Nephrology – Michael J.G. Somers, MD
  • Pregnancy and Renal Disease – Ravi I. Thadhani, MD, MPH
  • Dialysis Vascular Access: Assessment and Complications – Dirk Hentschel, MD
  • Geriatric Nephrology – Ernest I. Mandel, MD

CKD and General Nephrology

  • Update on Renovascular Disease – Joseph M. Garasic, MD
  • Management of Hypertension after SPRINT – Richard J. Glassock, MD
  • Secondary Hypertension: Primary Aldosteronism and Pheochromocytoma – Anand Vaidya, MD, MMSc
  • Cardiovascular Disease and Renal Disease – David M. Charytan, MD, MSc
  • Nephrology Board Review Practice 1 – David M. Charytan, MD, MSc

Acute Kidney Injury

  • Pathophysiology of Acute Kidney Injury – Joseph V. Bonventre, MD, PhD
  • Acute Kidney Injury Syndromes – Sushrut S. Waikar, MD, MPH
  • Cancer and Acute Kidney Injury – Albert Q. Lam, MD
  • Paraprotein Induced Kidney Injury – Albert Q. Lam, MD
  • Clinicopathological Conference – Richard Glassock, MD, Joel Henderson, MD, PhD, & Martina M. McGrath, MD
  • Cardiorenal and Hepatorenal Syndromes – David J.R. Steele, MD
  • FSGS: A Lesion, Not a Disease – Richard J. Glassock, MD
  • Interstitial Nephritis: Overview for the Boards – Li-Li Hsiao, MD, PhD
  • ICU Nephrology and Continuous Renal Replacement Therapies – Peter G. Czarnecki, MD

Transplantation

  • Why Do We Reject a Transplant? – Jamil R. Azzi, MD
  • Transplant Immunosuppression for the Boards – Steven Gabardi, PharmD, BCPS, FAST, FCCP
  • Immunological Assessment Pre and Post Transplant – Melissa Y. Yeung, MD & Indira Guleria, PhD
  • Early Post-Transplant Management – Anil K. Chandraker, MD
  • Late Post-Transplant Medical Complications – Leonardo V. Riella, MD, PhD
  • Late Loss of the Kidney Transplant – Andrew M. Siedlecki, MD
  • Infections in Transplant Recipients – Sarah P. Hammond, MD
  • Transplant Cases: Board Review Practice – Melissa Y. Yeung, MD & Edgar L. Milford, MD
  • Pre-Transplant Evaluation of Recipients – Jamil R. Azzi, MD, & Sayeed Malek, MD, FACS
  • Donor Evaluation – David Wojciechowski, DO
  • Thrombotic Microangiopathies – Jean M. Francis, MD
  • Transplant Board Review – Leonardo V. Riella, MD, PhD
  • Must Know Board Zebras – Emily S. Robinson, MD, MPH

Dialysis

  • Dialysis Dosing – J. Kevin Tucker, MD
  • Mineral and Bone Disease – David Bushinsky, MD
  • Dialysis: A Case-Based Clinical Review and Update – J. Kevin Tucker, MD
  • Pearls in Mineral and Bone Disease – David Bushinsky, MD
  • Renal Ultrasound for the Clinical Nephrologist – Adina S. Voiculescu, MD
  • Chronic Kidney Disease Epidemiology: A 2018 Update – Gearoid M. McMahon, MB BCh
  • Peritoneal Dialysis – Joanne M. Bargman, MD, FRCPC
  • Peritoneal Dialysis Complications – Joanne M. Bargman, MD, FRCPC
  • Poisonings and intoxications: What a Nephrologist Now Needs to Know – Timothy B. Erickson, MD
  • Nephrology Board Review Practice 2 – Finnian R. McCausland, MD
  • How to Pass the Boards – David E. Leaf, MD

Written by 

Leave a Reply

Your email address will not be published. Required fields are marked *